Prof Hope Rugo speaks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the recent advances in the use of PARP inhibitors for the treatment of metastatic breast cancer. She describes where we are currently with PARP...
Original Article: Advances in PARP inhibitor use for metastatic breast cancer